Remifentanil requirement for i-gel insertion is reduced in male patients with Parkinson’s disease undergoing deep brain stimulator implantation: an up-and-down sequential allocation trial

Overview of attention for article published in BMC Anesthesiology, June 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 19 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,329 followers.

RT @Ingentium_PD: Remifentanil requirement for i-gel insertion is reduced in male patients with Parkinson's disease undergoing deep brain s…

27 Jun 2022

Reply Repost Favourite

Remifentanil requirement for i-gel insertion is reduced in male patients with Parkinson's disease undergoing deep brain stimulator implantation: an up-and-down sequential allocation trial. https://t.co/OhoOROMVYh https://t.co/KbjSbuiQ8C

27 Jun 2022

Reply Repost Favourite

New article: Remifentanil requirement for i-gel insertion is reduced in male patients with Parkinson's disease undergoing deep brain stimulator implantation: an up-and-down sequential allocation trial https://t.co/Uk0m0t7hBv #parkinsons #neurology https://

25 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.